NeoStem Expands Adult Stem Cell Collection Network, Gains Footprint in Key Los Angeles...

NeoStem Expands Adult Stem Cell Collection Network, Gains Footprint in Key Los
Angeles Market and Initiates Waitlist

NEW YORK, July 31 /PRNewswire-FirstCall/ -- NeoStem, Inc. (Amex: NBS) has
announced that it has broadened its network of adult stem cell collection
centers. Through a development agreement with Stem Collect LLC, NeoStem has
added the Hall Center, a vibrant Santa Monica based medical practice.
The Los Angeles area is a significant healthcare market with many academic
medical centers and a large concentration of physician practices and hospitals
offering a dynamic and diverse population that focuses on healthcare and
wellness, as well as new healthcare technologies. To prepare for the demand
for collections at the new center, clients are being offered the opportunity
to join a waitlist by contacting NeoStem at 1-888-STEM BANK to hold a priority
position for an appointment once the center is open. It is expected that the
center will open in August.
Robin Smith, MD MBA, NeoStem's Chairman and Chief Executive Officer
commented: "Securing the Santa Monica site for a new collection center in our
network is an important step for us as we open collection centers in major
metropolitan areas to address the demand for cutting-edge healthcare options
by these sophisticated populations. The location, at the prestigious Hall
Center, offers a beautiful and comforting environment where our clients can
have a warm and inviting experience and will help service those clients we
anticipate drawing from an awareness program being launched in September."
Dr. Smith further commented, "Many believe that adult stem cells are
emerging as a modern day 'fountain of youth' and we are pleased to be at the
forefront of autologous adult stem cell collection and long term storage."
"At the Hall Center, we specialize in treatments and therapies designed to
help our patients stay healthy and optimize their physical and mental well
being," says Harold Liebowitz, MD, the Center's Medical Director. "We are
pleased and excited to bring the NeoStem process to our patients and give them
the opportunity to secure bio-insurance for their medical futures. There are
over 2,000 clinical trials that are using an individual's own stem cells to
treat their disease such as heart disease, Lupus, MS, Crohn's disease and
diabetes, just to name a few and we look forward to the future development of
these important therapies."
Dr. Liebowitz was trained in Internal Medicine at USC, and worked as an
Emergency and Trauma Physician for over 20 years. He has served as the Medical
Director at The Centinela Hospital Fitness Institute testing professional
athletes from The Lakers, Clippers, Dodgers and PGA golf tour. He was the team
Doctor for The Pioneer Triathlon Team, a professional triathlon team. He
served as a member of the medical Board for Tri-Fed, the governing body of the
Triathlon sport. He was a member of the advisory board of Bally Health and
Tennis, and 24 Hour Fitness. He also worked as a Physician at the Pritikin
Longevity Center.
About the Hall Center
The Hall Center specializes in cutting-edge offerings of "Functional
Medicine" -- a revolutionary science-based practice of medicine --
complimented by an array of holistic wellness services. Their innovative
approach seeks to simultaneously reverse unhealthy aging on multiple levels,
by integrating science-based Functional Medicine, Chinese Medicine, Homeopathy
and Energy Medicine.
About Stem Collect
Stem Collect plans to develop a network of NeoStem enabled stem cell
collection centers in key cities around the country. The Stem Collect network
is intended to make the simple process of stem cell collection and storage
available to millions of Americans where they live. As stem cell therapies
continue to grow, there will be the increased need for collection and storage
and Stem Collect intends to make that process simple and highly available
through its network of collection centers.
About NeoStem, Inc.
NeoStem is developing a network of adult stem cell collection centers,
enabling people to donate and store their own (autologous) stem cells when
they are young and healthy for their personal use in times of future medical
need. The Company has also recently entered into research and development
through the acquisition of a worldwide exclusive license to technology to
identify and isolate VSELs (very small embryonic-like stem cells), which have
been shown to have several physical characteristics that are generally found
in embryonic stem cells.
Forward-Looking Statements
This press release contains forward-looking statements within the meaning
of the Private Securities Litigation Reform Act of 1995. Forward-looking
statements reflect management's current expectations, as of the date of this
press release, and involve certain risks and uncertainties. The Company's
actual results could differ materially from those anticipated in these
forward-looking statements as a result of various factors. Factors that could
cause future results to materially differ from the recent results or those
projected in forward-looking statements include the "Risk Factors" described
in the Company's periodic filings with the Securities and Exchange Commission.
Contact:
NeoStem, Inc.
Robin Smith, Chief Executive Officer
T: 212-584-4180
E: rsmith@neostem.com
www.neostem.com

SOURCE NeoStem, Inc.

Robin Smith, Chief Executive Officer of NeoStem, Inc., +1-212-584-4180,
rsmith@neostem.com